LCI699/osilodrostat

osilodrostat · Recordati Group

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LCI699/osilodrostat, covering 2024-12-18 to 2024-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699 [Phase 2]